Inhibrx Biosciences (INBX) reported late Thursday its registrational study of ozekibart met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival compared with placebo in patients with advanced or metastatic, unresectable chondrosarcoma.
Shares of Inhibrx almost doubled as intraday trading volume catapulted to over 4.9 million from a daily average of about 151,000.
Comfort Systems USA (FIX) reported late Thursday a year-over-year growth in Q3 earnings and sales.
Its shares jumped 17%, with intraday trading volume at over 701,000 compared with a daily average of about 408,000.
MidWestOne Financial Group's (MOFG) shares jumped 33% after the bank posted an increase overnight in Q3 adjusted earnings.
Intraday trading volume advanced to more than 1.2 million shares from a daily average of about 124,000.
Price: 56.07, Change: +27.71, Percent Change: +97.71